Odyssey Therapeutics, Inc.
Biotechnology (biopharmaceuticals; immunology/autoimmune disease therapeutics) · Boston, MA
S-1 FiledODTX
Odyssey Therapeutics, Inc. IPO
Monitoring
S-1 Filed
Priced
Trading
Est. valuation
$100M
Exchange
—
Ticker: ODTX
Status
S-1 Filed
Filed
Apr 17, 2026
IPO timeline
Apr 17, 2026
S-1 filed with SEC
Initial registration statement submitted to the Securities and Exchange Commission.
Upcoming
Roadshow & pricing
Company presents to institutional investors. IPO price and share count are finalized.
Upcoming
First-day trading
Shares available on the open market.
Frequently asked questions
When is Odyssey Therapeutics, Inc. going public?
Odyssey Therapeutics, Inc. has not yet announced an IPO date or filed a registration statement with the SEC. FireStrike will update this page when official filings or announcements are made.
What is Odyssey Therapeutics, Inc.'s IPO valuation?
The estimated offering value is $100M. Final valuation will be determined at pricing.
What exchange will Odyssey Therapeutics, Inc. list on?
No exchange has been officially announced for the Odyssey Therapeutics, Inc. IPO.
Has Odyssey Therapeutics, Inc. filed an S-1 with the SEC?
No. As of the most recent data, Odyssey Therapeutics, Inc. has not filed a Form S-1 or other registration statement with the SEC.
Sources: FireStrike proprietary index · SEC EDGAR